NCT01764386 - Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects | Biotech Hunter

Enrollment

242

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

ObesityOverweight

Interventions

DRUG

Naltrexone SR 32 mg/Bupropion SR 360 mg (NB) in combination tablets (daily dosage)

BEHAVIORAL

CLI

The Comprehensive Lifestyle Intervention (CLI) program includes telephone counseling, internet education, goal setting, and online tracking tools.

BEHAVIORAL

Usual Care

Usual Care is a self-directed lifestyle intervention program

Trial Locations (15)

27518

PMG Research of Raleigh, Cary

27609

PMG Research of Raleigh, Raleigh

28144

PMG Research of Salisbury, Salisbury

28401

PMG Research of Wilmington, LLC, Wilmington

28601

PMG Research of Winston-Salem, Hickory

29464

PMG Research of Charleston, Mt. Pleasant

29621

Radiant Research, Anderson

29651

Radiant Research, Greer, Greer

37620

PMG Research of Bristol, Bristol

43212

Radiant Research, Inc., Columbus

44311

Radiant Research-Akron, Akron

63151

Radiant Research, Inc., St Louis

75231

Radiant Research Dallas-North, Dallas

80239

Radiant Research, Denver

84107

Radiant Research, SLC, Salt Lake City